Alterola Biotech, Inc. (ABTI) Financial Statements (2025 and earlier)

Company Profile

Business Address 47 HAMILTON SQUARE
BIRKENHEAD MERSEYSIDE, CH41 5AR
State of Incorp.
Fiscal Year End March 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2024
Q2
6/30/2024
Q1
3/31/2024
Q4
12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments714,2632,6542,5749,10236,5458,890
Cash and cash equivalents714,2632,6542,5749,10236,5458,890
Inventory, net of allowances, customer advances and progress billings1,0111,0091,0159751,009986
Inventory1,0111,0091,0159751,009986
Intangible current assets      
Other undisclosed current assets   187,131193,653227,308
Total current assets:715,2743,6633,589197,208231,207237,184
Noncurrent Assets
Deferred costs      
Deferred income tax assets    187,131193,653189,355
Other undisclosed noncurrent assets259,951  112,86912,268,19911,950,424
Total noncurrent assets:259,951  300,00012,461,85212,139,779
TOTAL ASSETS:975,2253,6633,589497,20812,693,05912,376,963
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,328,6121,187,6611,114,363968,494961,120866,669
Accounts payable868,248825,210803,841722,124677,988611,805
Accrued liabilities460,364362,451310,522246,370283,132254,864
Debt151,751145,603244,0611,550,7371,372,9471,260,434
Other undisclosed current liabilities959,679     
Total current liabilities:2,440,0421,333,2641,358,4242,519,2312,334,0672,127,103
Noncurrent Liabilities
Other undisclosed noncurrent liabilities      154,313
Total noncurrent liabilities:      154,313
Total liabilities:2,440,0421,333,2641,358,4242,519,2312,334,0672,281,416
Equity
Equity, attributable to parent, including:(1,375,898)(1,329,601)(1,354,835)(2,022,023)10,358,99210,095,547
Common stock1,467,4851,382,6441,382,663778,032807,048807,048
Treasury stock, value    (29,016)  
Additional paid in capital10,102,8919,663,9709,663,9717,581,44219,856,93018,927,919
Accumulated other comprehensive income (loss)35,62939,86010,97120,621(9,906)(63,173)
Accumulated deficit(12,981,903)(12,416,075)(12,441,456)(10,431,134)(10,295,080)(9,576,247)
Other undisclosed equity, attributable to parent   29,01658,032  
Equity, attributable to noncontrolling interest(88,919)     
Total equity:(1,464,817)(1,329,601)(1,354,835)(2,022,023)10,358,99210,095,547
TOTAL LIABILITIES AND EQUITY:975,2253,6633,589497,20812,693,05912,376,963

Income Statement (P&L) (USD)

9/30/2024
Q2
6/30/2024
Q1
3/31/2024
Q4
12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
Operating expenses(682,822)(284,326)(1,108,947)(123,155)(580,670)1,316,334
Other undisclosed operating loss  (3,647,984)    
Operating income (loss):(682,822)(3,932,310)(1,108,947)(123,155)(580,670)1,316,334
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
28,075 (901,375)(123,155)(138,163) 
Other undisclosed loss from continuing operations before equity method investments, income taxes  (266,061)    
Income (loss) from continuing operations before income taxes:(654,747)(4,198,371)(2,010,322)(246,310)(718,833)1,316,334
Other undisclosed income from continuing operations 88,919101,301    
Income (loss) from continuing operations:(565,828)(4,097,070)(2,010,322)(246,310)(718,833)1,316,334
Other undisclosed net loss (88,919)     
Net income (loss):(654,747)(4,097,070)(2,010,322)(246,310)(718,833)1,316,334
Net income attributable to noncontrolling interest88,919     
Other undisclosed net income (loss) attributable to parent(88,919)3,445,382 123,155 154,524
Net income (loss) available to common stockholders, diluted:(654,747)(651,688)(2,010,322)(123,155)(718,833)1,470,858

Comprehensive Income (USD)

9/30/2024
Q2
6/30/2024
Q1
3/31/2024
Q4
12/31/2023
Q3
9/30/2023
Q2
6/30/2023
Q1
3/31/2023
Q4
Net income (loss):(654,747)(4,097,070)(2,010,322)(246,310)(718,833)1,316,334
Other comprehensive loss      
Comprehensive income (loss):(654,747)(4,097,070)(2,010,322)(246,310)(718,833)1,316,334
Comprehensive income, net of tax, attributable to noncontrolling interest88,919     
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(93,150)(28,013)(9,650)  (136,721)
Comprehensive income (loss), net of tax, attributable to parent:(658,978)(4,125,083)(2,019,972)(246,310)(718,833)1,179,613

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: